1365ckESpf? wefaqmifrkef;vqef; 14 &uf /       2003ckESpf Edk0ifbmv 7 &uf/        twGJá7 ? trSwfá136
 
 
 
 


 

ygarmu© a'gufwmcifarmif0if;ESifh awGUqHkjcif;

áarouf0if;ESihf EG,fEG,fat;
1365ckESpf? wefaqmifrkef;vqef; 14 &uf /   2003ckESpf Edk0ifbmv 7 &uf/   twGJá7 ? trSwfá136
 

urÇmwGif a&yef;pm;vmaom tonf;a&m*g rsm;ESifh ywfoufí jrefrmjynfoljynfom; rsm; BudKwif umuG,fwm;qD;Edkif&efESifh a&m*g ukxHk;rsm;taMumif;udk &efukefaq;½kHBuD;? tonf;a&m*gXmerS ygarmu© a'gufwm cifarmif0if;ESifh awGUqHkar;jref;cJhygonf/

ygarmu©a'gufwmcifarmif0if;

Ä ,ckvuf½SdrSm tonf;a&m*g trsKd; tpm;ta&twGuf b,fESrsKd;avmuf½Sd ygovJ/
tckavmavmq,ftxdawmh ckepfrsKd; avmuf½Sdygw,f/ tonf;a&m*gydk;jzpfwJh at? tD;eJY tufzfwdkU[m tpm;taomufeJU a&uae ul;pufEdkifNyD; bD? pD? 'D? *sDwkdYu awmh aoG;oGif;wmwdkY ta&jym;udkxdk; azmufNyD; aq;xdk;wmwdkY aq;rifaMumifxdk; wmwdkY? em;azmufwmwdkYtjyif vdifqufqHrI wdkYaMumifhvnf; ul;pufEdkifygw,f/

Ä 'D ckepfrsKd;xJrSm b,fydk;u tul;puf vG,fqHk;jzpfNyD; tonf;uifqma&m*g jzpfzdkY tvm;tvm t½SdqHk;jzpfrvJ/
tonf;a&miftom;0gbDydk;u tqdk;qHk; jzpfNyD; ul;pufwmvnf; vsifjrefygw,f/ bDa&m*gydk;½Sdol[m tonf;uifqmjzpfzdkY twGuf 295 qydkNyD; tcGifhtvrf;½Sdygw,f/ attdkif'Dtufpfydk;eJY ,SOfr,fqdk&if tq wpf&m ydkNyD;ul;vG,fygw,f/ bDydk;ygwJhaoG; vufzuf&nfZGef; wpfZGef;rSm bDydk;a& ig;oef;cefYygEdkifNyD; HIV/AIDS ydk;ygwJhaoG; vufzuf&nfZGef;rSmawmh HIV ydk;ig;aumif yJ ygEdkifygw,f/

Ä bDydk;umuG,faq;b,fESrsKd; ½SdygovJ/
a&m*gjzpfwJhvl&JUaoG;&nfMunf Plasma Derived umuG,faq;udk aq;okawoe rSmxkwfvkyfygw,f/ urÇmrSmawmh Yeast u xkwfwJh Genetically Engineered (Recombinant) udk toHk;rsm;Muygw,f/

Ä bDa&m*g r½SdwJh olwpfa,muf[m umuG,faq; xdk;NyD;ayr,fh ay:vm wwfao;w,fqdkwm[kwfygovm;/
ay:wwfygw,f/ 'gayr,fh &mcdkifEIef; t&rf;enf;ygw,f/ aoG;uxkwfwhJhumuG,f aq;jzpfwJhtwGuf Antigen udk tylay;NyD; alumionium hydroxide eJYaygif;&if umuG,faq;jzpfygw,f/ tJ'D antigen udk cE¨mudk,fxJxdk;ay;&if a&m*gydk;udk wdkufzsuf wJh Anti body xGufvmygw,f/ 'gaMumifh wpfcgwav umuG,faq;xdk;NyD;vdkY aoG; ppfMunfh&if bDydk;ay:aewm awGU&wwfyg w,f/ 'guvnf; wpfywfftwGif;avmuf rSmygyJ/ HBsAg vdkYac:wJh bDydk;udkr,lbJ tcGHudkom,lNyD; a&m*gumuG,faq;xkwf xm;wJhtwGuf umuG,faq;aMumihfawmh a&m*grjzpfEdkifygbl;/ aoG;uawmh oefY& r,f/

Ä vlemawGuae wpfqifh ul;puffjcif; cH&wJh q&m0eftwGuf b,fvdkukorI awGvkyfEdkifygovJ/
vlemudkaq;xdk;&if;? 'grSr[kwf cGJpdwf&if; eJY ul;pufjcif;cH&wJh q&mawGtwGufu awmh passive immunisation vdkYac:whJ hepatitis B immune Globulin u a&m*gydk;udk wefjyefwdkufcdkufygw,f/ 'Daq; u xdk;NyD; 15 rdepftwGif; a&m*gydk;udk wdkufzsufygw,f/ q&m0eftaeeJY a&m*g umuG,faq;udkvnf; xdk;xm;oifhygw,f/

Ä uav;eJYvlBuD;awGrSm tonf;a&mif tom;0gbDydk;u b,fvdkul;pufjzpf yGm;ygovJ/
uav;i,fwpfOD; bDydk;ul;pufcH&&if 80 &mcdkifEIef;u vHk;0emvefrxlawmhbJ emwm ½Snf ydk;o,faqmifol Chronic Carrier jzpfoGm;ygw,f/ tJ'guawmh uav;&JU udk,fcHtm;u vHk;0 r½SdvdkYygyJ/ vlBuD;u udk,fcHtm;½SdwJh twGuf ydk;udk wefjyef wdkufcdkufEdkifygw,f/ vlBuD;rSm ul;puf&if awmh 20 &mcdkifEIef;avmufyJ chronic carrier jzpfEdkifygw,f/ 'gaMumifh uav;awGudk arG;NyD;NyD;csif; 12 em&DtwGif; umuG,f aq; xdk;ay;wm taumif;qHk;ygyJ/

Ä bDydk;ul;pufcH&wJh vlemwpfa,mufu ol[m emwm½Snfydk;o,faqmifoljzpf rjzpfqdkwmb,fvdkodEdkifygovJ q&m/
yxrtBudrf bDydk;½Sd r½Sdprf;oyf&ygw,f/prf;oyfNyD;aemuf ajcmufvMumvdkY jyefprf; oyfwJhtcg ½Sdaeao;&if emwm½Snfydk;o,f aqmifolvdkY owfrSwfEdkifygw,f/

Ä bDydk;ul;pufrIudk b,fvdk umuG,f EdkifygovJ/
umuG,frIuawmh usef;rma&; 0efxrf; awGuaewpfqifhp&rSmyg/ vlemwpfa,muf uae wpfa,muf rul;&atmif wpfcgoHk; aq;xdk;tyfwdkY? omrdkrDwmwdkY oHk;oifhyg w,f/ wpfcgoHk; roHk;Edkif&ifvnf; toHk;jyK r,fhud&d,mwefqmyvmawGudk a&aEG;eJY owfrSwfxm;wJhtylcsdefrSm xm;NyD; aygif;cH oefYpif&ygr,f/ a&m*gydk;½SdwJh vlemudk udkifwG,fprf;oyfwJhtcgrSm q&m0efu vuftdwf 0wfxm;oifhovdk vlemprf;wJh tdyfpifrSmvnf; wpfcgoHk;t0wfjzpfjzpf? puúLyJjzpfjzpf cif;xm;oifhygw,f/ vlem wpfa,muf tdyfvdkuf aemufwpfa,muf prf;oyfzdkY tdyfvdkufeJY a&m*gul;pufzdkYtcGifh tvrf;rsm;ygw,f/

vlxkynmay;taeeJY uawmh qGrf;auR; wJhtvSLawGrSm [if;csKdyef;uef wpfvHk; wnf;xm;r,fhtpm; wpfa,mufudk [if;csKd yef;uefvHk;wpfvHk;pD xm;ay;&if [if;csKd aomufwJh ZGef;uae a&m*gul;pufrIukd wm;qD;EdkifrSm jzpfygw,f/ vdifqufqHrI uaevnf; ul;pufEdkifwJhtwGuf vHkNcHK pdwfcswJh tumtuG,fypönf; (uGef'Hk;)udk oHk;oifhygw,f/

Ä bDydk;ul;pufNyD;wJholua&m a&m*gtajc taerqdk;atmif b,fvdkaexdkif oifhyg ovJ/
aq;vdyf? t&uf? bD,m pwmawGudk a½Smif&rSmjzpfwJhtjyif oH"mwfrsm;wJh tpm; tpmjzpfwJh aoG;cJ? tonf;tjrpf? uvDpm eJY oH"mwfygwJh tm;aq;awGudkyg a½Smif&rSm jzpfygw,f/ a[mfrkef;"mwfudka½SmifEdkif&if vnf; aumif;ygw,f/ qdk;aq;eJY qdk;xm;wJh tpm;tpmawGudkvnf; vHk;0a½Smif&ygr,f/

Ä bDydk;uae wpfqifh jzpfyGm;wwfwJh tonf;ajcmufa&m*g ½Sd r½Sdudka&m b,fvdkodEdkifygovJ/
tonf;tm;enf;wmudkawmh aoG;udk ppfaq;NyD; Liver function Test (LFT) vkyfNyD; odEdkifygw,f/ tonf;ajcmufw,f? usKHU w,f? jyKyfawGxaew,fqdk&ifawmh Ultrasound eJU CT scan ½kdufMunfhvdkY odEdkifyg w,f/ a&m*g tajctaeqdk;ae&if vufeJU udkifNyD;prf;oyf&ifawmifrS odEdkifygw,f/

Ä tonf;a&miftom;0g bDydk; owf aq;awGtaMumif;½Sif;jyay;ygOD;q&m/
wpfywf oHk;BudrfeJY ajcmufv xdk;&wJh tifwmz½Gefxdk;aq; ½Sdygw,f/ 'Dxdk;aq; twGuf ukefusp&dwfu odef;oHk;q,f0ef; usif ½Sdygw,f/ vmrDAsL'if;pm;aq;eJU odkifrdk pifxdk;aq;wdkUvnf; ½Sdygw,f/ vmrDAsL'if; u aomufaq;jzpfvdkY aomuff&wmvG,ful NyD; tifwmz½Gefxufvnf; tukeftus oufomygw,f/

Ä tonf;a&m*gpDydk;twGufa&m umuG,f aq;½Sdygovm;/
tckxufxdawmh pDydk;umuG,faq; r½Sd ao;ygbl;/ 'gaMumifh aoG;roGif;cifrSm aoG; udk aocsmppfoifhygw,f/ wpfpHkwpfckjzpf&if vlemyJcH&rSmrdkY aoG;oGif;wJhudpöawGrSm txl; yJ *½kpdkufoifhygw,f/

Ä pDa&m*gydk; ul;pufNyD;olawG[m b,f tcsdefus&if tonf;ajcmufa&m*g jzpf wwfygovJ/
pDydk;½SdolwpfOD;[m tESpf20 uae 25 ESpftwGif;rSm tonf;ajcmuf? 'grSr[kwf tonf;uifqmwdkY jzpfEdkifygw,f/

Ä pDydk;aysmufuif;atmif b,fvdkukxHk; awG ½SdygovJ/
ukorIudk rcH,lcifrSm aoG;xJrSm pDydk; yg0ifEIef;jzpfwJh Viral load vdkUac:wJh RNA udkprf;&ygr,f/ NyD;&if Genotype vdkY ac:wJh pDydk;trsKd;tpm;udk ppf&ygr,f/

Ä Genotype b,fESpfrsKd;½SdygovJ/
Genotype 1 uae 6 txd ½Sdygw,f/ 'DxJrSm 2 eJU 3 u odyfrqdk;ygbl;/ tifwm z½Gefxdk;aq;udk wpfywf oHk;BudrfeJY tenf; qHk; ajcmufvxdk;&ygr,f/ wjcm; Genotype trsKd;tpm;awGudkawmh yuftifwm z½Gef xdk;aq;udk &DbmAD&ifaomufaq;eJY wGJNyD; wpfywfwpfcgoHk;pGJ&ygr,f/xdk;aq; wpfvHk; u usyfav;odef;ukefuswJhtwGuf ukefus p&dwfawmh rsm;ygw,f/

Ä 'Dvdk ukorIawG cH,l&ifa&m a&m*g aysmufuif;Edkifygovm;/
80 &mcdkifEIef;u aocsmygw,f/ ukefus p&dwfrsm;wJhtwGuf tukefcHEdkifr,fqdk&if awmh aysmufuif;Edkifygw,f/

Ä pDydk;eJYywfoufNyD; jynfolvlxktaeeJU A[kokwa&m ½Sdygovm;/
vlxk&JU toduawmh tm;enf;aeyg w,f/ odoifhwJhtcsufuawmh tonf; uifqmjzpfyGm;rI&JU 50 &mcdkifEIef;u pDydk; aMumifh qdkwmygyJ/ vlxku pDydk;xuf bDydk; taMumif;udk ydkNyD; odem;vnfMuygw,f/pDydk;ul;puf&if 80 &mcdkifEIef;u rvGJraoG tonf;ajcmufa&m*gjzpfrSm jzpfygw,f/aiGtukeftusrcHEdkifwJhvlemawGtwGuf ao'PfcsrSwfxm;ovdk jzpfwmaMumifh rjzpfatmifBudKwifumuG,foifhygw,f/

owif;acgif;pOf

ájynfwGif;owif;

ápD;yGm;a&;u@

áEdkifiHa&;&mu@

áusef;rma&;ESifh vlrIa&;u@